Reduced-dose CHOP therapy for elderly patients with non-Hodgkin's lymphoma

Leukemia and Lymphoma

Volumn 41, Issue 3-4, 2001, Pages 359-366

  Mori, M ^a   Niitsu, N ^a   Takagi, T ^a   Tomiyama, J ^a   Matsue, T ^a   Nakagawa, Y ^a   Okamoto, R ^a  

^a Tokyo Metropolitan Institute of Gerontology   (Japan)

Author keywords

Chemotherapy; CHOP; Elderly; Non Hodgkin's lymphoma

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

AGED; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; ELDERLY CARE; FEMALE; HEART FAILURE; HEMATOLOGIC DISEASE; HUMAN; INFECTION; INTESTINE PERFORATION; KIDNEY FAILURE; LEUKOCYTE COUNT; LEUKOPENIA; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PERITONITIS; PNEUMONIA; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0034985710     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190109057991     Document Type: Article

References (19)

1. Prognostic factors for patients with diffuse large cell or immunoblastic non-Hodgkin's lymphoma: Experience of the non-Hodgkin's lymphoma pathologic classification project
2. The international non-Hodgkin's lymphoma prognostic Factor Project. A predictive model for aggressive non-Hodgkin's lymphoma
3. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non Hodgkin's lymphoma
4. Study of optimal CHOP dose ranges for elderly patients with non-Hodgkin's lymphoma
5. National cancer institute-sponsored study of classification of non-Hodgkin's lymphoma. Summary and description of a Working Formulation for clinical usage
6. Report of the Committee on Hodgkin's disease staging classification
7. The importance of dose intensity in the outcome of chemotherapy
8. Aggressive chemotherapy for diffuse histiocytic lymphoma in the elderly: Increased complications with advancing age
9. Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: The Southwest Oncology Group experience
10. Non-Hodgkin's lymphoma in the elderly. A study of 602 patients aged 70 or older from a Danish population-based registry
11. Non-Hodgkin's lymphoma in 137 patients aged 70 years or older: A retrospective European Organization for Research and Treatment of Cancer Lymphoma Group Study
12. Initial chemotherapy for clinically localized lymphoma of unfavorable histology
13. The role of dose intensity in determining outcome in intermediate-grade non-Hodgkin's lymphoma
14. Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: Results of a tree-structured survival analysis
15. Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy
16. Full dose CHOP chemotherapy in elderly patients with non-Hodgkin's lymphoma
17. Elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy plus granulocyte-macrophage colony- stimulating factor: Identification of two age subgroups with differing hematologic toxicity
18. A prospective study of a new combination chemotherapy regimen in patients older than 70 years with unfavorable non-Hodgkin's lymphoma
19. Elderly aggressive-history non-Hodgkin's lymphoma: First line VENCOP-B regimen experience in 350 patients